Research ArticleResearchWorkflow

A soft robotic glove did not outperform supervised stroke arm training

Journal of NeuroEngineering and Rehabilitation (PubMed)Sep 10, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

An assessor-blinded randomized trial found no significant advantage for a sensor-assisted soft robotic glove over supervised repetitive arm training during inpatient stroke rehabilitation.

What NurseJet pulled from the source

The trial randomized 61 adults with ischemic or hemorrhagic stroke and unilateral arm impairment; 58 completed the post-intervention assessment. Both groups improved after up to 15 sessions, but no statistically significant between-group differences were found in the primary or secondary outcomes.

Why this matters for nurses

Rehabilitation nurses reinforce prescribed practice, monitor tolerance, and help patients carry therapy goals into daily activity. The result does not support assuming that a robotic device is superior to a structured, supervised exercise program.

Bedside takeaway

Do not assume a robotic glove is better than structured supervised practice; follow the individualized stroke-rehabilitation plan.

Key takeaways

Participants received either robotic-glove training or supervised GRASP training for 30 to 45 minutes per session, up to five days weekly for three weeks.
A post-hoc subgroup signal for distal hand recovery favored the glove immediately after treatment but was not present at three months.
The trial stopped before reaching its planned sample size and was underpowered for the prespecified between-group difference.

Practice implications

Follow the individualized rehabilitation plan, help patients complete ordered repetitive upper-limb practice safely, and document fatigue, pain, skin issues, or barriers to participation. Present robotic devices as one possible therapy tool, not as proven superior treatment.

Limitations & cautions

The trial was underpowered after recruitment stopped for funding constraints. The exploratory subgroup finding was post hoc, involved 38 participants, and did not persist at three months; the device manufacturer was involved in funding and supplied the device.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Journal of NeuroEngineering and Rehabilitation (PubMed)

Journal of NeuroEngineering and Rehabilitation (PubMed). Efficacy of a soft robotic exoskeleton for upper-limb rehabilitation in subacute stroke inpatient rehabilitation: a randomised controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42763409/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Journal of Neurology (PubMed)Sep 20, 2026Systematic Review

A systematic review characterized cancer-associated coagulopathy stroke as an underrecognized ischemic stroke mechanism linked to advanced cancer, early recurrence, and poor outcomes.

Emergency OncologyAI summaryReview source

Systematic ReviewResearchMedication SafetyWorkflowAI summary · original source linked below

The qualitative review included 82 studies. Cancer-associated coagulopathy stroke occurred predominantly within six months of cancer diagnosis, most often with advanced or metastatic adenocarcinoma; D-dimer was the biomarker most consistently associated with recurrence and mortality, and reported 30-day mortality ranged from 25% to 50%.

Key takeaways

Lung and pancreatic adenocarcinomas were the histologic subtypes most frequently associated with cancer-related coagulopathy stroke.
Multiple infarcts across more than two vascular territories were a characteristic imaging pattern described in the review.
Low-molecular-weight heparin and direct oral anticoagulants were commonly used for secondary prevention, but the review did not establish one optimal antithrombotic strategy.

Why this matters on shift

Neuro and oncology nurses may be first to recognize a new focal deficit or recurrent neurologic change in a patient with active cancer. The review highlights a high-risk stroke mechanism that requires rapid assessment while leaving treatment selection to individualized multidisciplinary evaluation.

Bedside takeaway

Escalate new neurologic deficits immediately and communicate the patient's cancer and antithrombotic context to the stroke team.

Nursing implications

Treat any new focal neurologic deficit as an emergency, document onset and progression precisely, and promptly communicate active or metastatic cancer, recent cancer diagnosis, coagulation results, and current antithrombotic therapy to the stroke team. Follow facility stroke and anticoagulation protocols and provider orders.

Limitations & cautions

The review synthesized heterogeneous studies qualitatively and did not report a pooled treatment comparison. Biomarkers other than D-dimer had limited specificity, and the abstract does not support choosing one anticoagulant or screening strategy.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of Neurology (PubMed). Stroke secondary to cancer-associated coagulopathy: a systematic review.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Intensive & Critical Care Nursing (PubMed)Sep 7, 2026Systematic Review

A systematic review found that targeted emergency-department sepsis interventions improved guideline compliance and were associated with lower mortality and shorter time to antibiotics and fluids, although nearly all included studies used before-and-after designs.

Emergency ICUAI summaryReview source

Systematic ReviewResearchWorkflowQuality ImprovementAI summary · original source linked below

Across 56 studies, pooled compliance was higher during intervention periods (RR 1.71), mortality was lower (RR 0.80), and estimated time to antibiotics and fluids decreased by 32.5 and 20.4 minutes. Compliance results were highly heterogeneous, and only one study was randomized.

Key takeaways

The interventions were multimodal and context specific rather than a single standardized tool or protocol.
Bayesian analyses estimated a greater than 99% probability of some compliance improvement and a 97% probability of some mortality reduction under skeptical priors.
The antibiotic-timing estimate was sensitive to analyses that accounted for risk-of-bias assumptions.

Why this matters on shift

Emergency nurses are central to triage, screening, reassessment, specimen collection, treatment coordination, and escalation for suspected sepsis. The review supports reliable local systems for early recognition and timely protocol delivery, while its study designs limit causal certainty about any one intervention.

Bedside takeaway

Reliable screening, reassessment, escalation, and protocol execution matter; the evidence does not identify one universally superior ED sepsis intervention.

Nursing implications

Use the facility's validated sepsis-screening and escalation pathway, reassess patients when physiology or concern changes, and complete ordered time-critical care without bypassing contraindication checks or individualized provider orders. Report workflow barriers through the local quality process.

Limitations & cautions

Fifty-five of 56 studies used before-and-after designs, intervention components varied, and compliance heterogeneity was high. The pooled associations may reflect confounding and do not establish that a specific bundle caused the mortality difference.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Intensive & Critical Care Nursing (PubMed). Interventions to improve early recognition and management of sepsis in emergency departments: A systematic review and meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Acta Cirurgica Brasileira (PubMed)Sep 11, 2026Systematic Review

A systematic review of eight studies found possible benefits from negative-pressure wound therapy for partial- and full-thickness burns, including faster re-epithelialization in some studies and fewer dressing changes, but protocols and outcomes varied.

Med-Surg EmergencyAI summaryReview source

Systematic ReviewResearchWorkflowQuality ImprovementAI summary · original source linked below

The review included 466 patients across five randomized trials, two retrospective studies, and one prospective cohort. Three studies reported faster re-epithelialization with negative-pressure therapy; pressures ranged from 40 to 125 mmHg, and studies also assessed wound area, bacterial load, pain, graft integration, and scar quality.

Key takeaways

Only three of the eight included studies reported superiority for re-epithelialization time, so the finding was not uniform across the evidence base.
Studies reported possible reductions in wound area and bacterial load and described less frequent dressing changes as a logistical advantage.
Application difficulty and prolonged treatment in pediatric patients were identified as limitations.

Why this matters on shift

Burn and wound-care nurses manage seal integrity, drainage, pain, skin protection, dressing-change burden, and escalation for infection or graft concerns. The review suggests potential value for negative-pressure therapy while underscoring that device settings and patient selection must remain protocol directed.

Bedside takeaway

Use ordered negative-pressure therapy with close seal, drainage, skin, pain, and device monitoring; evidence for burn healing remains limited.

Nursing implications

When negative-pressure therapy is ordered for a burn, verify the prescribed pressure and mode, maintain the seal, document drainage and wound response, protect surrounding skin, and escalate pain, bleeding, infection concerns, or device failure through the burn or wound-care protocol.

Limitations & cautions

The evidence base comprised only eight studies with mixed designs, varied burn depth, different pressure settings, and heterogeneous outcomes. The abstract does not report pooled effect estimates or certainty ratings, so comparative effectiveness remains uncertain.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Acta Cirurgica Brasileira (PubMed). Effectiveness of negative-pressure wound therapy in partial-thickness and full-thickness burns: a systematic review.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Cancer-associated coagulopathy stroke carried high early recurrence and mortality risk

Multimodal ED sepsis interventions improved compliance and were associated with lower mortality

Negative-pressure therapy showed possible burn-healing benefits across eight small studies